Dermatology

Nemolizumab is an anti-IL-31Rα monoclonal antibody that has demonstrated clinical efficacy in two global Phase III studies (ARCADIA-1 and…

We are delighted to announce the release of the latest EMJ Dermatology journal! Inside you will find a diverse variety of content including…

Melanoma of the skin is a common type of cancer that primarily affects younger patients. In Stage III melanoma, which does not involve…

Dive into the latest issue of EMJ Dermatology, for an array of peer-reviewed articles, exclusive interviews with leading experts, and an…

This comprehensive review article explores patient-centric approaches in skin treatments, as presented by global experts during a…

The latest issue of EMJ Dermatology is out now and features a review of the European Academy of Dermatology and Venerology (EADV) Congress 2022.

Key learnings from a satellite symposium at the 9th Psoriasis: From Gene to Clinic Congress are summarised in an infographic exploring evolving understanding of IL-23 pathway inhibition in the treatment of psoriasis and psoriatic arthritis (PsA).

Exposure to the sun’s radiation can be harmful to the skin, and the degree of the damage caused is dependent on factors such as the…